People

Matthew Clement

news.yale.edualzheimersdata.orgalzheimer-europe.orglinkedin.com

Matthew Clement is identified by Yale’s October 2025 announcement as a director of Health & Life Sciences at Gates Ventures and director of scientific strategy at the Alzheimer’s Disease Data Initiative. Current Alzheimer Europe and ADDI materials describe his partnerships and scientific-strategy remit. His publicly documented research partnerships concern aging, Alzheimer’s disease and the responsible use of research data.